AU1533099A - Methods for evaluating immune function - Google Patents

Methods for evaluating immune function

Info

Publication number
AU1533099A
AU1533099A AU15330/99A AU1533099A AU1533099A AU 1533099 A AU1533099 A AU 1533099A AU 15330/99 A AU15330/99 A AU 15330/99A AU 1533099 A AU1533099 A AU 1533099A AU 1533099 A AU1533099 A AU 1533099A
Authority
AU
Australia
Prior art keywords
methods
immune function
evaluating immune
evaluating
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15330/99A
Inventor
Wieslawa K. Giermakowska
Ronald B. Moss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Response Corp
Original Assignee
Immune Response Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp filed Critical Immune Response Corp
Publication of AU1533099A publication Critical patent/AU1533099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • AIDS & HIV (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU15330/99A 1998-08-25 1998-11-25 Methods for evaluating immune function Abandoned AU1533099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9792898P 1998-08-25 1998-08-25
US60097928 1998-08-25
PCT/US1998/024917 WO2000011476A1 (en) 1998-08-25 1998-11-25 Methods for evaluating immune function

Publications (1)

Publication Number Publication Date
AU1533099A true AU1533099A (en) 2000-03-14

Family

ID=22265809

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15330/99A Abandoned AU1533099A (en) 1998-08-25 1998-11-25 Methods for evaluating immune function

Country Status (2)

Country Link
AU (1) AU1533099A (en)
WO (1) WO2000011476A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322928A1 (en) * 2002-04-11 2011-05-18 Cyclex, Inc. Method for monitoring the immune response and predicting clinical outcomes in transplant recipients using ATP measurement in lymphocytes
ATE437370T1 (en) * 2004-02-27 2009-08-15 Us Gov Health & Human Serv PHARMACODYNAMIC TESTS USING FLOW CYTOMETRY
US20050249699A1 (en) * 2004-05-05 2005-11-10 Stoff Jesse A Immunodynamic complexes and methods for using and preparing such complexes
EP1996936B1 (en) 2006-03-20 2010-08-04 St Vincent's Hospital Sydney Limited A method for detecting antigen-specific or mitogen-activated t cells
FR2935802B1 (en) * 2008-09-05 2012-12-28 Horiba Abx Sas METHOD AND DEVICE FOR CLASSIFYING, VISUALIZING AND EXPLORING BIOLOGICAL DATA
CN115774102A (en) * 2021-09-08 2023-03-10 复旦大学 Method for determining the state of a neocorona vaccine-mediated protective immune response

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1296622C (en) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system
IT1263256B (en) * 1992-11-05 1996-08-05 METHODOLOGY FOR THE REALIZATION OF A STIMULATED LYMPHOCYTAL TRANSFORMATION LABORATORY TEST IN FLOW CYTOFLUIMETRY.
JPH09502089A (en) * 1993-08-27 1997-03-04 ダナ−ファーバー キャンサー インスティチュート インコーポレイテッド Natural killer cell-specific antigen and antibody that identifies this antigen
EP0722330A4 (en) * 1993-10-07 1997-09-10 Systemix Inc Methods for analysis of human stem cells
AU4977896A (en) * 1995-02-17 1996-09-04 Immunotherapy, Inc. Immunotherapy screening, prognosis, and treatment methods and compositions

Also Published As

Publication number Publication date
WO2000011476A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AUPP328398A0 (en) Remove-a-line
AU5407599A (en) Sphingolipid-desaturase
AU1533099A (en) Methods for evaluating immune function
AU2609599A (en) Sensor-coupling
AU2706799A (en) Dynamometer
AU3254799A (en) Sorting wc-accession
AU3204999A (en) Futureball
AU6200799A (en) Improving immune function
AU2945599A (en) Immune response
AU1055399A (en) Rollerboard
AU3347599A (en) Aeromobile
AU5223199A (en) Bathtub-bathseat
AU9347498A (en) Imidazotriazolopyrimidines
AU2840799A (en) 1-phosphanorbornadienes
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AUPP412198A0 (en) Methods
AUPP410198A0 (en) Methods
AUPP408198A0 (en) Methods
AUPP222998A0 (en) Method
AU3432799A (en) Method
AUPP141098A0 (en) Method
AUPP764698A0 (en) Method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase